| Updates in endocrine immune-related adverse events in oncology immunotherapy S Coniac, M Stoian Acta Endocrinologica (Bucharest) 17 (2), 286, 2021 | 5 | 2021 |
| Real-World Outcomes of CDK4/6 Inhibitors Treatment in Metastatic Breast Cancer in Romania AI Miron, AV Anghel, AA Barnonschi, R Mitre, HD Liscu, E Găinariu, ... Diagnostics 13 (11), 1938, 2023 | 4 | 2023 |
| Challenges and Limitations of Endocrine Toxicity Evaluation in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy—Retrospective Study from a Tertiary-Level … S Coniac, MC Costache Outas, EE Pirvu, RI Patru, E Gainariu, C Aldea, ... Diagnostics 13 (10), 1788, 2023 | 4 | 2023 |
| Prediction of Subclinical and Clinical Multiple Organ Failure Dysfunction in Breast Cancer Patients—A Review Using AI Tools AI Ionescu, DI Atasiei, RT Ionescu, F Ultimescu, AA Barnonschi, ... Cancers 16 (2), 381, 2024 | 3 | 2024 |
| The Conditioning of Adjuvant Chemotherapy for Stage II and III Rectal Cancer Determined by Postoperative Pathological Characteristics in Romania HD Liscu, BR Liscu, R Mitre, IV Anghel, IL Antone-Iordache, A Balan, ... Medicina 59 (7), 1224, 2023 | 3 | 2023 |
| Correlations between Demographic, Clinical, and Paraclinical Variables and Outcomes in Patients with KRAS-Mutant or KRAS Wild-Type Metastatic Colorectal Cancer—A Retrospective … EE Pîrvu, E Severin, RI Pătru, I Niță, SA Toma, RR Macarie, ... Diagnostics 13 (18), 2930, 2023 | 1 | 2023 |
| Endocrine autoimmunity during immunotherapy for cancer-a snapshot from an Oncologic Institute in Romania E Lazar, I Andreescu, A Lazar, S Coniac, C Badiu Endocrine Abstracts 99, 2024 | | 2024 |
| Second primary breast cancer during PARP inhibitor treatment of somatic BRCA mutant ovarian cancer–a case report. DM Median, S Coniac, AI Miron Oncolog-Hematolog, 2023 | | 2023 |
